Skip to main content
SpringerLink
Log in

Complexity and the Onset of Psychosis

  • Chapter
  • First Online:
Handbook of Systems and Complexity in Health

Abstract

Psychotic illness refers to a group of psychiatric disorders that can be severe and enduring. The core symptoms of delusions and hallucinations affect the person’s ability and judgement on how to behave or how to respond to the world around them. The psychoses are usually grouped into three major categories: schizophrenia and schizophrenia-like illness, bipolar affective disorders (BPAD) and other affective psychoses and organic psychotic disorders. However, the psychotic symptoms can be seen in many other psychiatric and physical disorders as well as in normal healthy individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jones P, Murray RM. The genetics of Schizophrenia is the genetics of neurodevelopment. Br J Psychiatry. 1991;158:615–23.

    Article  PubMed  CAS  Google Scholar 

  2. Bullmore ET, Woodruff PW, Wright IC, Rabe-Hesketh S, Howard RJ, Shuriquie N, Murray RM. Does dysplasia cause anatomical disconnectivity in Schizophrenia? Schizophr Res. 1998;30:127–35.

    Article  PubMed  CAS  Google Scholar 

  3. Mc Donald C, Fearon P, Murray R. Neurodevelopmental hypothesis of Schizophrenia 12 years on: data and doubts. In: Rapoport J, editor. Childhood onset of “adult” psychopathology. Washington: American Psychiatric Press; 1999.

    Google Scholar 

  4. Murray RM, Lewis SW. Is Schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed). 1987;295:681–2.

    Article  CAS  Google Scholar 

  5. Boydell J, Van Os J, Mckenzie K, Murray RM. The association of inequality with the incidence of schizophrenia—an ecological study. Soc Psychiatry Psychiatr Epidemiol. 2004;39:597–9.

    Article  PubMed  CAS  Google Scholar 

  6. Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, Bebbington P, Jenkins R, Meltzer H. Prevalence and correlates of self- reported psychotic symptoms in the British population. Br J Psychiatry. 2004;185:298–305.

    Article  PubMed  Google Scholar 

  7. Cannon M, Caspi A, Moffit TE, Harrington H, Taylor A, Murray RM, Poulton R. Evidence for early—childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59:449–56.

    Article  PubMed  Google Scholar 

  8. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398–402.

    Article  PubMed  CAS  Google Scholar 

  9. Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardised scholastic test performance. Am J Psychiatry. 2002;159:1183–9.

    Article  PubMed  Google Scholar 

  10. Poulton R, Caspi A, Moffit TE, Cannon M, Murray R, Harrington H. Children’s self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry. 2001;57:1053–8.

    Article  Google Scholar 

  11. Hemsley DR. A simple (or simplistic?) cognitive model for schizophrenia. Behav Res Ther. 1993;31:633–45.

    Article  PubMed  CAS  Google Scholar 

  12. Gray J, Feldon J, Rawlins J, Hemsley D, et al. The neuropsychology of schizophrenia. Behav Brain Sci. 1991;14:1–84.

    Article  Google Scholar 

  13. Laruelle M, Abi-Dargham A, Van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci USA. 1996;93:9235–40.

    Article  PubMed  CAS  Google Scholar 

  14. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97:8104–9.

    Article  PubMed  CAS  Google Scholar 

  15. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry. 1999;46:56–72.

    Article  PubMed  CAS  Google Scholar 

  16. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13–23.

    Article  PubMed  Google Scholar 

  17. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev. 1998;28:309–69.

    Article  PubMed  CAS  Google Scholar 

  18. Laruelle M, Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol. 1999;13:358–71.

    Article  PubMed  CAS  Google Scholar 

  19. Howes OD, Montgomery AJ, Asselin M, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66:13–20.

    Article  PubMed  Google Scholar 

  20. Gray JA, Joseph MH, Hemsley DR, Young AM, Warburton EC, Boulenguez P, Grigoryan GA, Peters SL, Rawlins JN, Taib CT, et al. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res. 1995;71:19–31.

    Article  PubMed  CAS  Google Scholar 

  21. Grace A. Developmental dysregualtion of the dopamine system and the pathophysiology of schizophrenia. In: Keshavan MS, Kennedy J, Murray R, editors. Neurodevelopment and schizophrenia. Cambridge: Cambridge Press; 2004.

    Google Scholar 

  22. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET, et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157:16–25.

    PubMed  CAS  Google Scholar 

  23. Harrison PJ, Owen MJ. Genes for schizophrenia? recent findings and their pathophysiological implications. Lancet. 2003;361:417–9.

    Article  PubMed  CAS  Google Scholar 

  24. Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, Owen MJ, O’Donovan MC. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet. 2005;14:1947–54.

    Article  PubMed  CAS  Google Scholar 

  25. Carter CJ. Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res. 2006;86:1–14.

    Article  PubMed  CAS  Google Scholar 

  26. Gu Z, Jiang Q, Fu AKY, Ip NY, Yan Z. Regulation of NMDA receptors by neuregulin signalling in prefrontal cortex. J Neurosci. 2005;25:4974–84.

    Article  PubMed  CAS  Google Scholar 

  27. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression and neurobiology. Biol Psychiatry. 2006;60:132–40.

    Article  PubMed  CAS  Google Scholar 

  28. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10:40–68. image 5.

    Article  PubMed  CAS  Google Scholar 

  29. Munafo MR, Thiselton DL, Clark TG, Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:539–46.

    Article  PubMed  CAS  Google Scholar 

  30. Williams NM, O’Donovan MC, Owen MJ. Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophr Bull. 2005;31:800–5.

    Article  PubMed  Google Scholar 

  31. Egan MF, Te G, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 2001;98:6917–22.

    Article  PubMed  CAS  Google Scholar 

  32. Malhotra AK, Kestler ND, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652–4.

    Article  PubMed  Google Scholar 

  33. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A, Fananas L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry. 2004;161:1110–2.

    Article  PubMed  Google Scholar 

  34. Okochi T, Ikeele M, Kishi T, Kawashima K, Kiroshita Y, Kitajima T, et al. Meta-analysis of association between genetic variants in COMT and Schizophrenia: an update. Schizophr Res. 2009;110:140–8.

    Article  PubMed  Google Scholar 

  35. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron. 2006;52:139–53.

    Article  PubMed  CAS  Google Scholar 

  36. Williams HJ, Owen MJ, O’Donovan MC. Schizophrenia genetics: new insight from new approaches. Br Med Bull. 2009;91:61–74.

    Article  PubMed  Google Scholar 

  37. Rujescu D, Ingasin A, Cichon S, Pietilainen OPH, Barnes MR, Toulopoulou T, et al. Disruption of the Neurexin 1 gene is associated with schizophrenia. Hum Mol Genet. 2009;18:988–96.

    PubMed  CAS  Google Scholar 

  38. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry. 2002;159:1080–92.

    Article  PubMed  Google Scholar 

  39. Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O’Callaghan E, Stober G, Willinger MU, Wright P, Murray RM. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry. 1997;154:1220–7.

    PubMed  CAS  Google Scholar 

  40. Schulze K, McDonald C, Frangou S, Sham P, Grech A, Toulopoulou T, Walshe M, Sharma T, Sigmundsson T, Taylor M, Murray RM. Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives. Biol Psychiatry. 2003;53:562–70.

    Article  PubMed  Google Scholar 

  41. Stefanis N, Frangou S, Yakeley J, Sharma T, O’connell P, Morgan K, Sigmundsson T, Taylor M, Murray R. Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol Psychiatry. 1999;46:697–702.

    Article  PubMed  CAS  Google Scholar 

  42. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyper responsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 1993;9:67–75.

    PubMed  CAS  Google Scholar 

  43. Lipska BK, Luu S, Halim ND, Weinberger DR. Behavioural effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat. Behav Brain Res. 2003;141:105–11.

    Article  PubMed  Google Scholar 

  44. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs and schizophrenia: a search for common ground. Schizophr Res. 1995;16:87–110.

    Article  PubMed  CAS  Google Scholar 

  45. Boksa P, El-Khodor BF. Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev. 2003;27:91–101.

    Article  PubMed  CAS  Google Scholar 

  46. Flagstad P, Mork A, Glenthoj BY, Van Beek J, Micheal-Titus AT, Didriksen M. Disruption of neurogenesis on gestational day 17 in the rat causes behavioural changes revelant to positive and negative schizophrenia symptoms and alters amphetamine- induced dopamine release in nucleus accumbens. Neuropsychopharmacology. 2004;29:2052–64.

    Article  PubMed  CAS  Google Scholar 

  47. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry. 2002;185:196–204.

    Article  Google Scholar 

  48. Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC, Chiang YL, Ree SC, Lee CH, Murray RM. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33:1407–14.

    Article  PubMed  CAS  Google Scholar 

  49. Soulsby B, Dazzan P, Chitnis X, Wood S, Suckling J, McGuire P, McGorry P, Murray R, Velakoulis D, Phillips L, Yung A, Pantelis C. Grey matter abnormalities before the onset of psychosis: an automated MR image analysis. In: The 12th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine; 2004, Kyoto, Japan

    Google Scholar 

  50. Tsapakis E-M, Guillin O, Murray RM. Does dopamine sensitization underlie the association between schizophrenia and drug abuse? Curr Opin Psychiatry. 2003;16 Suppl 2:S45–52.

    Article  Google Scholar 

  51. Lewis DA, Lieberman JA. Catching up on Schizophrenia: natural history and neurobiology. Neuron. 2000;28:325–34.

    Article  PubMed  CAS  Google Scholar 

  52. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50:884–97.

    Article  PubMed  CAS  Google Scholar 

  53. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:110–7.

    Article  PubMed  Google Scholar 

  54. Caspi A, Moffit TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci. 2006;7:583–90.

    Article  PubMed  CAS  Google Scholar 

  55. Caspi A, Moffit TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57:1117–27.

    Article  PubMed  CAS  Google Scholar 

  56. Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, et al. High Potency cannabis and the risk of psychosis. Br J Psychiatry. 2009;195:488–91.

    Article  PubMed  Google Scholar 

  57. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O’Carroll C, et al. Modulation of mediotemporal and ventrostriatal function in humans by Δ9-THC. A neural basis for the effects of Cannabis Sativa on learning and psychosis. Arch Gen Psychiatry. 2009;66:442–51.

    Article  PubMed  CAS  Google Scholar 

  58. Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, Brenneisen R, et al. Disruption of frontal lobe coherence by Δ9-THC is associated with positive psychotic symptoms. Neuropsychopharmacology. 2011;36:827–36.

    Article  PubMed  CAS  Google Scholar 

  59. Cantor-Graae E, Selten J. Schizophrenia and migration: a meta-analysis. Schizophr Res. 2004;67:63.

    Article  Google Scholar 

  60. Fearon P, Kirkbride JB, Morgan C, Dazzan P, Morgan K, Lloyd T, Hutchinson G, Tarrant J, Fung WLA, Holloway J, Mallett R, Harrison G, Leff J, Jones PB, Murray RM, Group AS. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study. Psychol Med. 2006;36:1541–50.

    Article  PubMed  Google Scholar 

  61. Fearon P, Morgan C. Environmental factors in schizophrenia: the role of migrant studies. Schizophr Bull. 2006;32:405–8.

    Article  PubMed  Google Scholar 

  62. Boydell J, Van Os J, McKenzie K, Allardyce J, Goel R, McCreadie RG, Murray RM. Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. BMJ. 2001;323:1336–8.

    Article  PubMed  CAS  Google Scholar 

  63. Sharpley M, Hutchinson G, McKenzie K, Murray RM. Understanding the excess of psychosis among the African-Caribbean population in England. Review of current hypotheses. Br J Psychiatry Suppl. 2001;40:S60–8.

    Article  PubMed  CAS  Google Scholar 

  64. Reininghaus UA, Craig TKJ, Fisher HL, Hutchinson G, Fearon P, Morgan K, Dazzan P, Doody GA, Jones PB, Murray R, Morgan C. Ethnic identity, perceptions of disadvantage and psychosis: findings from the AESOP study. Schizophr Res. 2010;124:43–8.

    Article  PubMed  Google Scholar 

  65. Cooper C, Morgan C, Byrne M, Dazzan P, Morgan K, Hutchinson G, Doody GA, Harrison G, et al. Perceptions of disadvantage, ethnicity and psychosis. Br J Psychiatry. 2008;192:185–90.

    Article  PubMed  Google Scholar 

  66. Reininghaus UA, Morgan C, Simpson J, Dazzan P, Morgan K, Doody GA, Bhugra D, Leff J, Jones P, Murray R, et al. Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP study. Soc Psychiatry Psychiatr Epidemiol. 2008;43:743–51.

    Article  PubMed  Google Scholar 

  67. Heidbreder CA, Foxton R, Cilia J, Hughes ZA, Shah AJ, Atkins A, Hunter AJ, Hagan JJ, Jones DN. Increased responsiveness of dopamine to atypical, but not to typical antipsychotics in the medical prefrontal cortex of rats reared in isolation. Psychopharmacology (Berl). 2001;156:338–51.

    Article  CAS  Google Scholar 

  68. Selten J-P, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Curr opin Psychiatr. 2007;20:111–5.

    Article  Google Scholar 

  69. Selten J-P, Cantor-Graae E. Social defeat: risk factor for schizophrenia? Br J Psychiatry. 2005;187:101–2.

    Article  PubMed  Google Scholar 

  70. Selten J-P, Cantor-Graae E. Hypothesis: social defeat is a risk factor for schizophrenia. Br J Psychiatry. 2007;181:s9–12.

    Article  Google Scholar 

  71. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O, Nader SH, Buchheimer N, Ehrenkaufer RL, Nader MA. Social dominance in monkeys: dopamine D2 receptors and cocaine self- administration. Nat Neurosci. 2002;5:169–74.

    Article  PubMed  CAS  Google Scholar 

  72. Morgan C, Charalambides M, Hutchinson G, Murray RM. Migration, ethnicity and psychosis: toward a sociodevelopmental model. Schizophr Bull. 2010;36:655–64.

    Article  PubMed  Google Scholar 

  73. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenic mechanism. Am J Psychiatry. 1998;155:1661–70.

    PubMed  CAS  Google Scholar 

  74. Lawrie SM, Whalley HC, Abukmeil SS, Kestelman JN, Miller P, Best JJ, Owens DG, Johnstone EC. Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms. Br J Psychiatry. 2002;181:138–43.

    PubMed  Google Scholar 

  75. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281–8.

    Article  PubMed  Google Scholar 

  76. Phillips LJ, Velakoulis D, Pantelis C, Wood S, Yuen HP, Yung AR, Desmond P, Brewer W, McGorry PD. Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophr Res. 2002;58:145–58.

    Article  PubMed  Google Scholar 

  77. Whalley HC, Simonotto E, Flett S, Marshall I, Ebmeier KP, Owens DG, Goddard NH, Johnstone EC, Lawrie SM. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain. 2004;127:478–90.

    Article  PubMed  CAS  Google Scholar 

  78. Cahn W, Pol HE, Lems EB, Van Haren NE, Schnack HG, Van Der Linden JA, Schothorst PF, Van Engeland H, Kahn RS. Brain volume changes in first episode schizophrenia: a 1 year follow-up study. Arch Gen Psychiatry. 2002;59:1002–10.

    Article  PubMed  Google Scholar 

  79. Weinberger D, Marenco S. Schizophrenia as a neurodevelopmental disorder. In: Hirsch s, Weinberger D, editors. Schizophrenia (second edition). Oxford: Blackwell press; 2003.

    Google Scholar 

  80. Weinberger DR, Mcclure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59:553–8.

    Article  PubMed  Google Scholar 

  81. Cotter D, Pariante CM. Stress and the progression of the developmental hypothesis of schizophrenia. Br J Psychiatry. 2002;181:363–5.

    Article  PubMed  Google Scholar 

  82. Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulby B, Wood SJ, Brewer W, et al. Pituitary volume in psychosis. Br J Psychiatry. 2004;185:5–10.

    Article  PubMed  Google Scholar 

  83. Tandon R, Mazzara C, Dequardo J, Craig KA, Meador-woodruff JH, Goldman R, Greden JF. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome. Biol Psychiatry. 1991;29:953–64.

    Article  PubMed  CAS  Google Scholar 

  84. Bebbington P, Wilkins S, Jones P, Foerster A, Murray R, Toone B, Lewis S. Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry. 1993;162:72–9.

    Article  PubMed  CAS  Google Scholar 

  85. Myin-Germeys I, Van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry. 2001;58:1137–44.

    Article  PubMed  CAS  Google Scholar 

  86. Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulby B, Brewer WJ, Smith DJ, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra high risk of developing psychosis. Biol Psychiatry. 2005;58:417–23.

    Article  PubMed  Google Scholar 

  87. Mondelli V, Pariante C, Navari S, Aas M, D’Albenzio A, Di Forti M, Handley R, Hepqul N, et al. Higher cortisol levels are associated with smaller left hippocampal volume in first episode psychosis. Schizophr Res. 2010;119:75–8.

    Article  PubMed  Google Scholar 

  88. Borgwardt SJ, McGuire PK, Aston J, Berger G, Dazzan P, Gschwandtner UTE, Pfluger M, D’Souza M, et al. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry. 2007;191:569–75.

    Article  Google Scholar 

  89. Morgan KD, Dazzan P, Orr KG, Hutchinson G, Chitnis X, Suckling J, Lythgoe D, et al. Grey matter abnormalities in first episode schizophrenia and affective psychosis. Br J Psychiatry. 2007;191:s111–6.

    Article  Google Scholar 

  90. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31:189–95.

    Article  PubMed  CAS  Google Scholar 

  91. Holmes E, Steel C. Schizotypy: a vulnerability factor for traumatic intrusions. J Nerv Ment Dis. 2004;192:28–34.

    Article  PubMed  Google Scholar 

  92. McGhie A, Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 1961;34:103–16.

    Article  PubMed  CAS  Google Scholar 

  93. Rachman S, De Silva P. Abnormal and normal obsessions. Behav Res Ther. 1978;16:233–48.

    Article  PubMed  CAS  Google Scholar 

  94. Pm S, Harrison J. Abnormal and normal obsessions-a replication. Behav Res Ther. 1984;22:549–52.

    Article  Google Scholar 

  95. Morrison AP, Bentall RP, French P, Walford L, Kilcommons A, Knight A, et al. Randomised controlled trials of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. Br J Psychiatry Suppl. 2002;43:S78–84.

    Article  PubMed  CAS  Google Scholar 

  96. Maher B. Anomalous experience and delusional thinking: The logic of explanations. In: Oltmanns TF, Maher BA, editors. Delusional beliefs. Chichester: Wiley; 1988. p. 15–33.

    Article  PubMed  Google Scholar 

  97. Krabbendam L, Myin-Germeys I, Hanssen M, Bijl RV, De Graaf R, Vollebergh W, Bak M, Van Os J. Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation. Acta Psychiatr Scand. 2004;110:264–72.

    Article  PubMed  CAS  Google Scholar 

  98. Garety P, Hemsley D. Delusions: investigations into the psychology of delusional reasoning, Maudsley monograph. Hove: Psychology press; 1994.

    Google Scholar 

  99. Broome MR, Johns LC, Valli I, Wolley JB, Tabraham P, Brett C, Valmaggia L, Peters E, McGuire PK. Delusion formation and reasoning biases in those at clinical high risk of psychosis. Br J Psychiatry. 2007;191:s38–42.

    Article  Google Scholar 

  100. Bentall RP, Kinderman P, Kaney S. The self, attributional processes and abnormal beliefs: Towards a model of persecutory delusions. Behav Res Ther. 1994;32:331–41.

    Article  PubMed  Google Scholar 

  101. Frith CD. The Cognitive Neuropsychology of Schizophrenia. LEA: Hove, UK. 1992.

    Article  PubMed  Google Scholar 

  102. Hodges A, Byrne M, Grant E, Johnstone E. People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh high-risk study. Br J Psychiatry. 1999;174:547–53.

    Article  PubMed  CAS  Google Scholar 

  103. Van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res. 2000;45:11–20.

    Article  PubMed  Google Scholar 

  104. Strumwasser F. The human mind: building bridges between neuroscience and psychiatry. Psychiatry. 2003;66:22–31.

    Article  PubMed  Google Scholar 

  105. Peled A. The neurophysics of psychiatric diagnosis: clinical brain profiling. Med hypothesis. 2011;76(1):34–49.

    Article  Google Scholar 

  106. Johns LC, Van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev. 2001;21:1125–41.

    Article  PubMed  CAS  Google Scholar 

  107. Verdoux H, Van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr Res. 2002;54:59–65.

    Article  PubMed  Google Scholar 

  108. Cornblatt B, Lencz T, Obuchowski M. The Schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Res. 2004;67:63.

    Article  Google Scholar 

  109. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualisations. Schizophr Bull. 1996;22:353–70.

    Article  PubMed  CAS  Google Scholar 

  110. Yung AR, Phillips LJ, Pd MG, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ. Prediction of psychosis-a step towards indicated prevention of schizophrenia. Br J Psychiatry. 1998;172:14–20.

    CAS  Google Scholar 

  111. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res. 2003;60:21–32.

    Article  PubMed  Google Scholar 

  112. Hambrecht M, Lammertink M, Klosterkotter J, Matuschek E, Pukrop R. Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. Br J Psychiatry Suppl. 2002;43:s30–7.

    Article  PubMed  Google Scholar 

  113. Yung AR, Yuen HP, Berger GE, Francey S, Hung T-C, McGorry P. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33:673–81.

    Article  PubMed  Google Scholar 

  114. Van Os J, Delespaul P. Toward a world consensus on prevention of schizophrenia. Dialogues Clin Neuro­sci. 2005;7:53–67.

    PubMed  Google Scholar 

  115. Hanssen M, Bak M, Bijl R, Vollebergh W, Van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Psychiatry. 2005;44:181–91.

    Article  Google Scholar 

  116. Broome MR, Woolley JB, Johns LC, Valmaggia LR, Tabraham P, Gafoor R, Bramon E, McGuire PK. Outreach and support in South London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry. 2005;20:372–8.

    Article  PubMed  Google Scholar 

  117. Escher S, Romme M, Buiks A, Delespaul P, Van Os J. Independent course of childhood auditory hallucinations: a 3-year follow-up study. Br J Psychiatry Suppl. 2002;43:s10–8.

    Article  PubMed  Google Scholar 

  118. An Der Heiden W, Hafner H. The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2000;250:292–303.

    Article  PubMed  CAS  Google Scholar 

  119. Freeman D, Garety P. Comments on the content of persecutory delusions: does the definition need clarifying? Br J Clin Psychol. 2000;39:407–14.

    Article  PubMed  Google Scholar 

  120. Broome MR, McGuire PK. Imaging and delusions. In: Freeman D, Bentall R, Garety PA, editors. Persecutory delusions: assessment, theory and treatment. Oxford: Oxford university press; 2008.

    Google Scholar 

  121. Freeman D. Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev. 2007;27:425–57.

    Article  PubMed  Google Scholar 

  122. Bortolotti L, Broome MR. Delusional beliefs and reasoning giving. Philos Psychol. 2008;21:821–41.

    Article  Google Scholar 

  123. Bortolotti L, Broome MR. The future of scientific psychiatry. In: Broome M, Bortolotti L, editors. Psychiatry as cognitive neuroscience: philosophical perspectives. Oxford: Oxford University Press; 2009.

    Google Scholar 

  124. Bortolotti L, Broome MR. A role of ownership and authorship in the analysis of thought insertion. Phenomenol Cogn Sci. 2009;8:205–24.

    Article  Google Scholar 

  125. Raballo A, Laroi F. Clinical Staging: a new scenario for the treatment of psychosis. Lancet. 2009;374:365–7.

    Article  PubMed  Google Scholar 

  126. Owen MJ, O’Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of Schizophrenia: reappraisal. Br J Psychiatry. 2011;198:173–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Taylor and Francis for permission to use some material from Broome M, Dale J, Marriott C, Merino C, Bortolotti L. Neuroscience, continua and the prodromal phase of psychosis. In: Fusar-Poli P, Borgwardt S, McGuire PK, editors. Vulnerability to psychosis: from psychopathology to neurosciences: Routledge; 2012. p. 1–22.

Author information

Authors and Affiliations

  1. Coventry and Warwickshire Partnership NHS Trust, The Caludon Centre, Coventry, UK

    Rajkumar Kamatchi

  2. Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK

    Rajkumar Kamatchi & Matthew R. Broome

  3. Coventry and Warwickshire Partnership NHS Trust, Coventry, UK

    Matthew R. Broome

Authors
  1. Rajkumar Kamatchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew R. Broome
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajkumar Kamatchi .

Editor information

Editors and Affiliations

  1. , Department of General Practice, Monash University, PO Box 3010, Wamberal, 2260, New South Wales, Australia

    Joachim P. Sturmberg

  2. Northern Ontario School of Medicine, Merchandise Mart Plaza, Suite 1212 222, Chicago, 60654, Illinois, USA

    Carmel M. Martin

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kamatchi, R., Broome, M.R. (2013). Complexity and the Onset of Psychosis. In: Sturmberg, J., Martin, C. (eds) Handbook of Systems and Complexity in Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4998-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4998-0_21

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4997-3

  • Online ISBN: 978-1-4614-4998-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation